CRISPR Therapeutics AG
CRSP · Healthcare · $5.3B
$55.89+1.04%
Price
$60.08
$57.00
Jul 2, 26Oct 1, 26
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
RevenueOperating IncomeNet Income
6/'26
Revenue$10M+598.3%
Operating Income-$117M+10.0%
Net Income-$91M+25.8%
3/'26 vs prev quarter
Company Health
Market Cap$5.3B
Operating Margin-3990.0%
Cash on Hand$2.4B44.3% of market cap
Free Cash Flow$-371M-7.0% of market cap
Among 327 Biotechnology peers
LowMedianHigh
PSR398.4xmedian 11.7xPBR3.0xmedian 2.1xROE-25.8%median -54.5%
